Skip to content

Clinical Evaluation of Local Calcitriol Delivery on Maxillary Canine Retraction

Clinical Evaluation of Local Calcitriol Delivery on Maxillary Canine Retraction

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07200349
Acronym
CALCR25
Enrollment
22
Registered
2025-10-01
Start date
2025-11-01
Completion date
2026-10-31
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Local Calcitriol Delivery, Maxillary Canine Retraction, Orthodontic Tooth Movement

Keywords

Calcitriol, Vitamin D3, Canine Retraction, Split-mouth Trial

Brief summary

This study will evaluate the effect of locally applied Calcitriol on dental and skeletal changes during upper canine retraction. It is a split-mouth randomized clinical trial, where Calcitriol will be locally applied on one side of the maxilla, and the other side will serve as control.

Detailed description

Orthodontic tooth movement depends on bone remodeling. This study investigates if Calcitriol, the active form of vitamin D3, can affect this process when applied locally during upper canine retraction. The study is designed as a split-mouth randomized clinical trial. Patients needing maxillary first premolar extraction will be included. Calcitriol will be locally applied on one side, and the other will serve as a control. The study will evaluate dental and skeletal changes to see if Calcitriol improves treatment outcomes.

Interventions

DRUGCalcitriol Delivery

Local delivery of Calcitriol (active form of vitamin D3) to one side of the maxillary canine area during orthodontic treatment. The aim is to assess its effect on dental and skeletal changes during canine retraction in a split-mouth design.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a parallel design with two groups based on Vitamin D status. Each participant receives a split-mouth intervention with Calcitriol on one side and no treatment on the other side

Eligibility

Sex/Gender
ALL
Age
13 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Presence of class I malocclusion requiring bilateral extraction of the maxillary first premolars and subsequent canine retraction. 2. Presence of class II malocclusion requiring bilateral extraction of the maxillary first premolars and subsequent canine retraction. 3. Age range between 13 and 35 years to include both adolescent and adult patients suitable for orthodontic treatment. 4. Presence of permanent dentition. 5. Good oral hygiene.

Exclusion criteria

1. History of chronic systemic disease. 2. Presence of active gingival or periodontal disease. 3. Known allergy or hypersensitivity to vitamin D. 4. Pregnancy or lactation. 5. History of previous orthodontic treatment. 6. Presence of craniofacial anomalies affecting bone physiology.

Design outcomes

Primary

MeasureTime frameDescription
Amount of maxillary canine retraction (mm) assessed on CBCT scansT0: immediately before maxillary canine retraction. T1: after completion of canine retraction (approximately 4 months - 6 months)The amount of maxillary canine movement will be assessed using cone-beam computed tomography (CBCT). Measurements will be expressed in millimeters

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026